Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03128619
Title Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

Copanlisib + Letrozole + Palbociclib

Copanlisib + Letrozole

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.